MARATTO

article · OALib

Visible Malformations in Mice, Mus musculus Experimentally Exposed in Utero to Antimalarials (Manalaria®, Syrup Kilma® versus Quinine)

20231 citationOpen accessUniversité de Kinshasa (UNIKIN)

Abstract

The antimalarial phytomedicines, Manalaria and Sirop Kilma, also frequently used in Kinshasa at the start of pregnancy, would not have previously undergone embryotoxicity tests.This study aims to determine the embryotoxicity of Manalaria and Sirop Kilma on mice, Mus musculus.An experimental study in which 54 prepubescent mice were exposed during embryogenesis, including 16 mice to Manalaria, 20 to Syrup Kilma and 18 to Quinine.Careful observation by visual inspection and enlarged photography enabled the search for malformations in the exposed mice.As a result, all the mice exposed to the 3 antimalarials did not reveal visible malformations on visual inspection or on enlarged photography.In conclusion, under the experimental conditions of this study, no visible malformation was observed in mice exposed to the two phytomedicines in utero.

Research topics

  • Science, Research, and Medicine
  • Pluripotent Stem Cells Research
  • Effects and risks of endocrine disrupting chemicals

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4236/oalib.1110140

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.